TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in The Impact of Event Scale - Revised (IES-R) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in The Memorial Symptom Assessment Scale (MSAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stoma specific quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants Free From Respiratory Failure at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With at Least a 1-point Improvement in Clinical Status on Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage to care for TB disease treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical Composite Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in skin melanin index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Magnitude of forearm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility in Number of patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weight Gain at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: O'Leary-Sant Interstitial Cystitis Index (OLSICI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delay in seeking care
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Thiol/Disulphide Homeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of injury
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perception of injury
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Longitudinally Measured Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Longitudinally Measured Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fathers' Attachment Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dysphagia Severity Rating Scale (DSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest compressions fraction (CCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural inhibitory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural negative emotionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported current alcohol consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feeding Amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymphocyte subpopulations in blood before freezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte subpopulations in blood after freezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte subpopulations in urine before freezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte subpopulations in urine after freezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sustained virologic response after treatment (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm delivery (before 37 weeks' gestation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of Participants Discontinuing Study Drug Due to AEs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Caregiving burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in ICIQ-OABqol
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in ICIQ-OAB
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in frequency of urination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children receiving the first dose of the HPV vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of postoperative burst abdomen
Endpoint domain: Adverse events/effects
Primary endpoint: Evolution of individual naming scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of discourse
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Protocol completion without deviation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of participants appropriately referred for a follow-up weight check
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cortical tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Body Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tendon integrity of the rotator cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower limb joints range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC Subjective Knee Form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the size of wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maturity rate of arteriovenous fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) survey score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of thyroid abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean activation of regions subserving emotion, emotion regulation, and attention processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean deactivation of the Default Mode Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage Healing Index on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Healing Index on day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity index-GMT of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dual-task cost in cognition (Reaction time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual-task cost in gait (gait speed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual-task cost in cognition (Accuracy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Fat Oxidation Rate (MFO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Depression and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility-days of practice
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility-daily duration of practice
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with perioperative renal function worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Abundance of microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of at least 50% in pain scores on the visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in at least 50% in pain scores on the Pain Anxiety Symptoms Scale -- Short Form 20 (PASS SF-20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At least 10% of study participants to experience one or more significant adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention Efficacy based on Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subject willingness to wear a wireless patch system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Serum BDNF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum Irisin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Stroop Reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fitlight reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saccade frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saccade amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saccade velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic properties
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Survey of Parental Expectations and Knowledge (SPEAK)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parental Cognition and Conduct Toward the Infant Scale (PACOTIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MacArthur-Bates Communicative Development Inventories-Short Form (MCDI-SF)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: StimQ - Reading Subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence rate of delayed polypectomy bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: TTV replication kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical repigmentation changes of vitiligo lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Stool Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in pain: visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of pain at rest and on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ketogenic diet compliance score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of systemic volume overload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite neonatal adverse outcomes (CNAO)
Endpoint domain: Adverse events/effects
Primary endpoint: specific airway volume (siVaw) upon inspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: specific airway resistance (siRaw) upon inspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: urinary C-C motif chemokine 14 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased frequency of increased voiding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: primary objective
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Number of Patients Who Registered With the MindCotine Application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Patients With Interest in the MindCotine Application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Patients Who Would Recommend the MindCotine Application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Viral-capsid Protein 1 (VP1)-Specific Antibody Secreting Cells (ASC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Norovirus G1.1 Histo-blood Group Antigen (HBGA) Blocking Antibodies (BT50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VP1 Serum Immunoglobin G (IgG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Genetic profile sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in Preschool Speech Intelligibility Measure Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of urinary cytology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of PcCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle area at T7 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ASIA impairment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of Life quality assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: knowledge and skills of volunteer work
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Difference in latency of cortical auditory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in latency of cortical auditory evoked potentials due to stuttering intervention program
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in amplitude of cortical auditory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in amplitude of cortical auditory evoked potentials due to stuttering intervention program
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area Under the Serum Concentration Time Profile from Time Zero to 168 hrs (AUC0-168)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Catastrophizing Scale (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in physical symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in psychological symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Molecular Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of KDS-1001
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Infectious/Antibiotic Complications
Endpoint domain: Adverse events/effects
Primary endpoint: duration of healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuro Recovery Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of anastomotic dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiver Strain Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under receiver operating characteristic curves (AUROC) of preoperative IVCCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss (ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Periodic trace elements in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Task Load Index (TLX) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percent of glucose time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Elevated level of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baxter Retching Faces Scale (BARF)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in mean serum phosphorus level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stabilization of brain networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of neurometabolites measured by Magnetic Resonance Spectroscopy (MRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Color assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of PtCO2 variation for exhumation failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Eating disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional hospital stay
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-operative analgesic duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Open Wound Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion of Shoulder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Acromion-GreaterTuberosity Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fugl-Meyer assessment in upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acute GVHD rate
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic GVHD rate
Endpoint domain: Adverse events/effects
Primary endpoint: Serum LRG1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follicular fluid LRG1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum SREBP1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follicular SREBP1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative hepatitis B surface antibody (HBsAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Grade 3 or higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: HIV viral load increase greater than 1 log(10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Insulin sensitivity M value change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: white matter disease volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of clinically relevant statin-associated musculoskeletal events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The Stroke Rehabilitation Assessment of Movement (STREAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Fugl-Meyer Assessment (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Barthel Scale/Index (BI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Stroke Specific Quality of Life scale (SS-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in mean arterial blood pressure (MAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of post-spinal hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Response Rate (ORR) of Enoblituzumab Plus Retifanlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate (ORR) of Enoblituzumab Plus Tebotelimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Adverse Events (AEs) Receiving Enoblituzumab Plus Tebotelimab
Endpoint domain: Adverse events/effects
Primary endpoint: Enhancement of sexual awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Concentration Time Curve (AUC) From Hour 0 to 24 Hours Post-Dose (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mask acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage behavioral response of trained dogs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pupillary Dilatation Reflex (PDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants with Serum ALT Levels >3 × ULN
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of units of Red Blood Cells (RBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in circulating concentrations of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: differential cost per QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of injected exosomes
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical efficacy of injected exosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Receiving Guideline-Concordant Septic Shock Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention